Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-related Wet Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT05269966
What this trial is testing

Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Novartis Pharmaceuticals 105
Testing effectiveness (Phase 2)Study completedNCT03479372
What this trial is testing

Study of PAN-90806 Eye Drops, Suspension for Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
PanOptica, Inc. 51
Not applicableStudy completedNCT03290794
What this trial is testing

Structured Post-marketing Surveillance to Collect the Safety Data of Intravitreal Aflibercept Injection (IVT-AFL) in Patients of Wet Age-related Macular Degeneration During Real World Clinical Practice

Who this might be right for
Wet Age-related Macular Degeneration
Bayer 100
Early research (Phase 1)Ended earlyNCT04594681
What this trial is testing

A Safety Study of KHK4951 in Healthy Volunteers and Patients With Wet Age-Related Macular Degeneration

Who this might be right for
Healthy VolunteersWet Age-related Macular Degeneration
Kyowa Kirin Co., Ltd. 116
Post-approval studies (Phase 4)Study completedNCT06330220
What this trial is testing

Visual Function Change in Wet Age-related Macular Degeneration Patients With Better Baseline Visual Acuity

Who this might be right for
Age-Related Macular Degeneration
Seoul National University Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT00464347
What this trial is testing

TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 100
Testing effectiveness (Phase 2)Study completedNCT03558061
What this trial is testing

Evaluate the Effects and Safety of ALK4290 in Patients With Newly Diagnosed Wet Age-Related Macular Degeneration

Who this might be right for
Wet Age-related Macular Degeneration
Alkahest, Inc. 30
Early research (Phase 1)Study completedNCT07484074
What this trial is testing

A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324

Who this might be right for
Diabetic Macular Edema (DME)Neovascular (Wet) Age-Related Macular Degeneration
Ollin Biosciences, Inc. 164
Testing effectiveness (Phase 2)Study completedNCT01494805
What this trial is testing

Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration

Who this might be right for
Macular DegenerationAge-related MaculopathiesAge-related Maculopathy+5 more
Lions Eye Institute, Perth, Western Australia 40
Post-approval studies (Phase 4)UnknownNCT01961414
What this trial is testing

Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910

Who this might be right for
Exudative Age-related Macular Degeneration
Palmetto Retina Center, LLC 45
Large-scale testing (Phase 3)Looking for participantsNCT06952452
What this trial is testing

Pharmacogenomics of antiVEGF in Patients With Age-Associated Macular Degeneration (AMD)

Who this might be right for
Wet Age-related Macular Degeneration
Parc de Salut Mar 630
Not applicableStudy completedNCT02540369
What this trial is testing

To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada.

Who this might be right for
Wet Macular Degeneration
Bayer 2,150
Large-scale testing (Phase 3)Active Not RecruitingNCT06556368
What this trial is testing

Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK

Who this might be right for
Wet Age-related Macular Degeneration
Kodiak Sciences Inc 675
Early research (Phase 1)Study completedNCT04782271
What this trial is testing

Safety, Tolerability and Pharmacokinetic Profile of SYL1801 Eye Drops

Who this might be right for
Safety, Tolerability and Pharmacokinetic Profile in Healthy VolunteersChoroidal Neovascularization
Sylentis, S.A. 36
Testing effectiveness (Phase 2)UnknownNCT04564937
What this trial is testing

The Study of Drug SCT510A in Patients With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Sinocelltech Ltd. 66
Post-approval studies (Phase 4)Study completedNCT01453920
What this trial is testing

Wet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab Dosing

Who this might be right for
Age Related Macular Degeneration
University Health Network, Toronto 44
Large-scale testing (Phase 3)UnknownNCT03609307
What this trial is testing

Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical Trial

Who this might be right for
Age Related Macular Degeneration
Shahid Beheshti University of Medical Sciences 40
Early research (Phase 1)Study completedNCT04747197
What this trial is testing

First in Human Study to Evaluate the Safety and Tolerability of EYP-1901 in Patients With Wet Age Related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
EyePoint Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT04640272
What this trial is testing

A Multi-Center, Open Label, Extension Study Assessing the Efficacy and Safety of Additional Intravitreal Injections of RBM-007 in Subjects With Wet Age-related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Ribomic USA Inc 40
Large-scale testing (Phase 3)Active Not RecruitingNCT06856577
What this trial is testing

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Wet AMD
Adverum Biotechnologies, Inc. 311
Next Page